Neurocrine Biosciences
NBIX
NBIX
325 hedge funds and large institutions have $7.8B invested in Neurocrine Biosciences in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 142 increasing their positions, 98 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
325
Holders Change
-5
Holders Change %
-1.52%
% of All Funds
7.05%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
45
Increased
142
Reduced
98
Closed
49
Calls
$108M
Puts
$77.1M
Net Calls
+$30.9M
Net Calls Change
+$2.03M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$118M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$79.4M |
| 3 |
HM
HealthCor Management
New York
|
+$65.9M |
| 4 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$61.3M |
| 5 |
Millennium Management
New York
|
+$47.5M |
